ClinicalTrials.Veeva

Menu

Assessment of Augmented Reality in Minimally Invasive Surgery

I

IGI Technologies

Status

Unknown

Conditions

Laparoscopic Hepatectomy
Laparoscopic Liver Thermal Ablation

Treatments

Device: LapAR

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT03678220
2R42CA192504 (U.S. NIH Grant/Contract)
LAPAR01

Details and patient eligibility

About

The objective of this study is to test the technical feasibility of LapAR visualization system for guiding laparoscopic surgeries and to gather clinical feedback on the use of this tool.

Full description

Surgeons use real-time video generated by a laparoscope to visualize the operative field when performing laparoscopic procedures. An inability to see beneath organ surfaces is a limitation of the current visualization technology. Surgeons additionally use laparoscopic ultrasound to see beneath organ surfaces, but also need to mentally correlate the ultrasound image with the video of the operative field. This process is difficult, subjective, and variable with expertise, and discourages the use of ultrasound.

The investigators have developed a method to combine live laparoscopic video and laparoscopic ultrasound images to present fused multimodality images on a single display, eliminating the need for mental image correlation. Specifically, the image fusion method, called laparoscopic augmented reality (LapAR), augments the laparoscopic video with ultrasound data when required by surgeons. This study is designed to test this minimal-risk capability in patients referred for relevant laparoscopic procedures.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient is referred for either laparoscopic partial hepatectomy for tumor removal or laparoscopic ablation of liver cancer;
  2. Patient must be at least 18 years old;
  3. Patient provides written consent;
  4. Patient is considered a suitable candidate based on tumor location for using the AR system.

Exclusion criteria

Patients with pacemaker or any other ICD(intra-cardiac device) which may interfere with electromagnetic tracking

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Patients using LapAR system
Experimental group
Treatment:
Device: LapAR

Trial contacts and locations

1

Loading...

Central trial contact

Raj Shekhar, PhD; William Plishker, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems